Targeting Hims & Hers, F.D.A. Takes on a New Type of Drug Advertisernews2025-09-12T22:09:11+00:00September 12th, 2025|The New York Times|
California Passes Bill Allowing Omission of Patients’ Names From Abortion Pill Bottlesnews2025-09-11T17:21:43+00:00September 11th, 2025|The New York Times|
Patients Cut Off From Cheaper Obesity Drugs as FDA Halts Sales of Copycatsnews2025-04-16T14:43:02+00:00April 16th, 2025|The New York Times|
Eli Lilly’s Popular Weight Loss Drug, Zepbound, Is Getting a Price Cutnews2024-08-27T10:45:07+00:00August 27th, 2024|The New York Times|
Compounded Semaglutide: What to Know About Overdose Risks of Ozempic Alternativenews2024-08-06T15:00:05+00:00August 6th, 2024|The New York Times|
It’s Time to Ban Pharmaceutical Advertisingnews2024-06-19T16:21:58+00:00June 19th, 2024|The New York Times|
How Supplement Stores Are Trying to Tap Into the Ozempic Boomnews2024-04-29T23:03:41+00:00April 29th, 2024|The New York Times|
CVS and Walgreens Will Begin Selling Abortion Pills This Monthnews2024-03-01T18:37:21+00:00March 1st, 2024|The New York Times|
Abortion Shield Laws: A New War Between the Statesnews2024-02-22T21:00:41+00:00February 22nd, 2024|The New York Times|
Use of ADHD Drugs Surged During Pandemic, Study Findsnews2024-01-10T17:25:09+00:00January 10th, 2024|The New York Times|
